View Author
fviii patient willebrand ddavp von willebrand disease vwd type 1 disease response factor vwf multimers vwf parameters level blood multimer study group mutation type 1 type 2 von willebrand factor >250 erasmus univ rotterdam fviii /vwf ratio treatment surgery parameter vwf /fviii loading dose value table michiel recessive haemate-p type 2 vwd thromb haematol loading vwd patients missense domain infusion blood group /fviii alphanate allele prophylaxi hemate-p rotterdam vwf deficiency half life times vwd type 3 erasmu abo blood group deficiency plasma berneman gadisseur pattern schroyen effect recovery thrombosis downloaded cat.sagepub.com type 3 vwd dosing defect type 1 vwd wilfactin vliet laboratory mannucci immunate absence berneman z 12 hours carrier vwf multimeric pattern correction
3 Most Recent Publications
|
Laboratory diagnosis and molecular basis of mild von willebrand disease type 1
(Article)
Michiels, J.J. Berneman, Z. Gadisseur, A. Planken, M. van der Schroyens, W. Vliet, H.H.D.M. van |
2009-06-01
|
|
Managing patients with von willebrand disease type 1, 2 and 3 with desmopressin and von willebrand factor-factor VIII concentrate in surgical settings
(Article)
Michiels, J.J. Vliet, H.H.D.M. van Berneman, Z. Schroyens, W. Gadisseur, A. |
2009-06-01
|
|
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients with von Willebrand disease type 1, 2 and 3
(Article)
Michiels, J.J. Vliet, H.H.D.M. van Berneman, Z. Gadisseur, A. Planken, M. van der Schroyens, W. Velden, A. van der Budde, U. |
2007-01-01
|
